RSS Feed
Tags
adaptive trials advertising advisory committees best practices biologics biosimilar biotech BLA cancer Cato BioVentures Cato Research CBER CDER CDRH clinical trials CMC conference DDMAC DIA drug development eCTD efficacy FDA GlobalSubmit guest post guidance IND inspections medical devices NDA NIH nonclinical research oncology outsourcing personalized medicine postmarketing protocol safety slides Social Media statistical analysis transparency venture capital warning letters webinarCategories
Archives
Links
Follow us on Twitter!
- Featured yesterday at Fierce Biotech IT - Cato lists five keys to success in adaptive trials http://bit.ly/aHry0A about 17 hours ago from TweetDeck
- RT @reuters: "Outgunned FDA tries to get tough with drug ads" http://bit.ly/btorHn 08:45:47 PM September 07, 2010 from web
- @MicroConstants Thanks for retweeting! 07:27:43 PM September 07, 2010 from TweetDeckin reply to MicroConstants
- New blog post: August 2010 FDA Guidances - http://ask-cato.com/mg 02:50:26 PM September 07, 2010 from WordTwit Plugin
Tag Archives: advertising
DDMAC Sends Warning Letter Over Unbranded Websites
If you judge, investigate. – Seneca I know you just read the title, but let me say it again with some emphasis: DDMAC Sends Warning Letter Over Unbranded Websites. That’s right, a warning letter over websites that contained no “direct” … Continue reading
Posted in FDA, Industry News
Tagged 21 CFR, accelerated approval, advertising, CDER, clinical trials, DDMAC, FDA, first-line treatment, Gleevac, Novartis, off label promotion, oncology, unbranded websites, warning letters
2 Comments
First Example of Proposed DTC Rules in Effect?
No one can possibly know what is about to happen: it is happening, each time, for the first time, for the only time. – James Arthur Baldwin Hey, remember those proposed DTC advertising rules that the FDA published recently? Well, … Continue reading
Posted in FDA, Industry News
Tagged advertising, DDMAC, direct to consumer, DTC, FDA, guidance, warning letters
Comments Off
FDA Proposes New Direct-to-Consumer (DTC) Advertising Rules
Good advertising does not just circulate information. It penetrates the public mind with desires and belief. – Leo Burnett The FDA recently published a proposed rule for how risk information should be presented in Direct-to-Consumer (DTC) advertising. Per FDAAA 2007, … Continue reading
Posted in FDA, Industry News
Tagged advertising, DDMAC, direct to consumer, DTC, FDA, FDAAA 2007, Federal Register, guidance, radio, rules, TV
Comments Off
